John Cox Dyne Therapeutics, Inc. (DYN) insider trading activity

DYN Quotes by TradingView

John Cox is CEO & President of Dyne Therapeutics, Inc.. Currently has a direct ownership of 202,179 shares of DYN, which is worth approximately $1.88 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K
38.25% 3M change
n/a 12M change
Total Value Held $1.88 Million

John Cox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 15 2025
SELL
Bona fide gift
-
40,000 Reduced 16.52%
202,179 Common Stock
Jul 14 2025
BUY
Open market or private purchase
$911,000 $9.11 p/Share
100,000 Added 29.22%
242,179 Common Stock
Jun 05 2025
SELL
Open market or private sale
$54,201 $13.35 p/Share
4,060 Reduced 2.78%
142,179 Common Stock
Mar 05 2025
SELL
Open market or private sale
$48,041 $11.83 p/Share
4,061 Reduced 2.7%
146,239 Common Stock
Dec 04 2024
BUY
Grant, award, or other acquisition
-
145,300 Added 49.15%
150,300 Common Stock

Also insider at

SGTX
Sigilon Therapeutics, Inc. Healthcare
JC

John Cox

CEO & President
Cambridge, MA

Track Institutional and Insider Activities on DYN

Follow Dyne Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

News

Receive news related to Dyne Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DYN